Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2026-09-14 16:59:28 ET · period of report 2026-09-10 · accession 0002001011-26-000140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 16:59 | 2026-09-10 | LGND | Zimmermann Martine | Dir | S - Sale | $285.00 | -1,200 | 3,897 | -24% | -$342.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | S | D | 1,200 | $285.00 | 3,897 | D | — | — |